Hydroxylated Tropolones Inhibit Hepatitis B Virus Replication by Blocking Viral Ribonuclease H Activity

Hepatitis B virus (HBV) remains a major human pathogen despite the development of both antiviral drugs and a vaccine, in part because the current therapies do not suppress HBV replication far enough to eradicate the virus. Here, we screened 51 troponoid compounds for their ability to suppress HBV RN...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Lu, Gaofeng, Lomonosova, Elena, Cheng, Xiaohong, Moran, Eileen A., Meyers, Marvin J., Le Grice, Stuart F. J., Thomas, Craig J., Jiang, Jian-kang, Meck, Christine, Hirsch, Danielle R., D'Erasmo, Michael P., Suyabatmaz, Duygu M., Murelli, Ryan P., Tavis, John E.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2015
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335860/
https://ncbi.nlm.nih.gov/pubmed/25451058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04617-14
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares